MetaADEDB 2.0 @ LMMD
Taurine
(XOAAWQZATWQOTB-UHFFFAOYSA-N)
Structure
SMILES
NCCS(=O)(=O)O
Type(s)
Approved; Nutraceutical
Molecular Formula:
C2H7NO3S
Molecular Weight:
125.147
Log P:
0.6140
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
2
TPSA:
88.77
CAS Number(s):
107-35-7
Synonym(s)
1.
Taurine
2.
Taufon
3.
Tauphon
4.
Taurine Hydrochloride
5.
Taurine Zinc Salt (2:1)
6.
Taurine, Monopotassium Salt
External Link(s)
MeSHD013654
PubChem Compound1123
4068592
BindingDB50357220
ChEBI507393
15891
CHEMBLCHEMBL239243
DrugBankDB01956
DrugCentral4486
IUPHAR/BPS Guide to PHARMACOLOGY2379
KEGGcpd:C00245
dr:D00047
Therapeutic Target DatabaseD0C6IE
ZINC3809490
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AbasiaOFFSIDES
2Acute Lung Injury19362168CTD
3Acute kidney injury28987951CTD
4Ammonia increasedOFFSIDES
5AmnesiaOFFSIDES
6AmphetaminesOFFSIDES
7Anti-neutrophil cytoplasmic antibody positive vasculitisOFFSIDES
8Arsenic Poisoning19672740CTD
9Arthritis, Experimental24709313CTD
10ArthritisOFFSIDES
11AstheniaOFFSIDES
12Asthenozoospermia25542992CTD
13Basal cell carcinomaOFFSIDES
14Blood alkaline phosphatase increasedOFFSIDES
15Blood creatinine increasedOFFSIDES
16Blood phosphorus decreasedOFFSIDES
17Blood potassium decreasedOFFSIDES
18Blood potassium increasedOFFSIDES
19Blurred visionOFFSIDES
20Bradycardia1451572
6621821		CTD
21Cardiomyopathies15231041CTD
22Cardiotoxicity26335259CTD
23Chemical and Drug Induced Liver Injury

View details

9328219
20166895
20830294
23092809
25213677
26335259
28987951
30677399
 		CTD
24Cholestasis, Extrahepatic27501764CTD
25Cognition Disorders24885898CTD
26ConfabulationOFFSIDES
27Conjunctival depositOFFSIDES
28Diabetes Mellitus, Experimental22138235
23092809		CTD
29Diabetic Cardiomyopathies16025228
22138235		CTD
30Disseminated Intravascular CoagulationOFFSIDES
31Drug resistanceOFFSIDES
32Drug withdrawal headacheOFFSIDES
33DysgraphiaOFFSIDES
34Dyslipidemias22138235CTD
35Edema15743398
27501764		CTD
36Endotoxemia20056113CTD
37ErythemaOFFSIDES
38Fanconi Syndrome10063969CTD
39FatigueOFFSIDES
40Fibrosis19362168CTD
41FlatulenceOFFSIDES
42Gliosis28987951CTD
43GlobulinuriaOFFSIDES
44Heart Diseases18561905
19616567		CTD
45Hemorrhage15743398CTD
46Hepatitis BOFFSIDES
47Hyperglycemia22138235
23092809		CTD
48Hyperpigmentation20804622CTD
49Hypertrophy19553346CTD
50Hypotension1451572
6621821
26335259		CTD
51Hypoxia2501810CTD
52ImmobileOFFSIDES
53IncoherentOFFSIDES
54IncontinenceOFFSIDES
55Inflammation21470069
27501764
30677399		CTD
56Intention tremorOFFSIDES
57Kidney Diseases

View details

17698946
18414974
19672740
20067817
25213677
 		CTD
58Liver Cirrhosis, Experimental15893842
15931870
25448286		CTD
59Lymphocyte count decreasedOFFSIDES
60Malignant neoplasm progressionOFFSIDES
61Mallory-Weiss SyndromeOFFSIDES
62Mammary Neoplasms, Experimental30101532CTD
63Movement Disorders2727012CTD
64Muscle Weakness26930420CTD
OFFSIDES
65Muscular Atrophy16318624CTD
66Muscular Dystrophy, Duchenne26930420CTD
67Myocardial Infarction16259760
19120009		CTD
68Necrosis20166895
27501764		CTD
69Nervous tensionOFFSIDES
70Non-alcoholic Fatty Liver Disease30237538CTD
71Obsessive thoughtsOFFSIDES
72Oligospermia19429265
20498001
25542992		CTD
73PainOFFSIDES
74Pancreatic Diseases30551535
30660605		CTD
75Pharmaceutical product complaintOFFSIDES
76PleurisyOFFSIDES
77Pneumonia19362168CTD
78PolyuriaOFFSIDES
79Proteinuria20360751CTD
80Pulmonary Fibrosis29078374CTD
81Respiratory tract congestionOFFSIDES
82Retinal Vein OcclusionOFFSIDES
83Seizures

View details

1276935
2501810
11140358
17728537
 		CTD
84Stevens-Johnson SyndromeOFFSIDES
85Testicular Diseases19429265
28987951		CTD
86Vanishing bile duct syndromeOFFSIDES
87Ventricular Dysfunction, Left26335259CTD
88Walking aid userOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.